Abeona Therapeutics Inc (ABEO) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Abeona Therapeutics Inc   (NASDAQ: ABEO)
 

Abeona Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Abeona Therapeutics Inc inventory turnover ratio, the Abeona Therapeutics Inc 's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 2.46 in the third quarter 2026, yet the ratio remained below the average, as ABEO's market remain challenging.Average inventory processing period, for the Abeona Therapeutics Inc in Sep 30 2026 quarter, has decreased to 148 days, compare to 242 days, in the Jun 30 2026 quarter.

Within Healthcare sector 159 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1477 in the second quarter 2026, to 1859.

ABEO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Abeona Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABEO Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth -3.84 % 120.44 % - - -
Y / Y Cost of Sales Growth 1070.7 % - - - -
Inventory Turnover Ratio (TTM) 2.46 1.51 0.89 0.47 0.26
ABEO's Total Ranking # 1859 # 1477 # 0 # 0 #
Average inventory processing period 148 242 412 776 1409
Seq. Inventory Growth -21.23 % -2.2 % 10.21 % 13.26 % 80.57 %
Seq. Cost of Sales Growth 36.77 % 54.93 % 158.24 % 113.93 % -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 43
Healthcare Sector # 160
Overall Market # 1859

Inventory Turnover Ratio Statistics
High Average Low
5.4 2.91 0.89
(Dec 31 2012)   (Mar 31 2026)



ABEO Company Profile >> Back to ABEO Efficiency Comparisons >> Compare ABEO Inventory Turnover Ratio to its Competitors

Financial Statements
Abeona Therapeutics Inc 's Inventories $ 5 Millions Visit ABEO's Balance sheet
Abeona Therapeutics Inc 's Cost of Revenues TTM $ 14 Millions Visit ABEO's Income Statement
What are ABEO's Sales? Visit ABEO's Sales by Segment

Other Inventory Turnover Ratios
Abeona Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ABEO's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ABEO's Competitors
Inventory Turnover Ratio for ABEO's Suppliers
Inventory Turnover Ratio for ABEO's Customers

You may also want to know
ABEO's Sales Growth Rates ABEO's Pe Price to earnings ratio ABEO's Receivables Turnover Ratio ABEO's Stock Quote
ABEO's Net Income Growth Rates ABEO's Ps Price to Sales ratio ABEO's Sales per Employee ABEO's Asset Turnover Ratio
ABEO's Net Margin ABEO's Pb Price to Book ratio ABEO's Financial Strength Ratios ABEO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Cardiff Lexington Corporation  6.98 $ 3.768  Millions$ 1  Millions
Carlsmed Inc   6.91 $ 15.844  Millions$ 2  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Coherus Oncology inc   3.50 $ 16.193  Millions$ 5  Millions

Date modified: 2026-11-11T10:17:58+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.